Vue transversale globale
Toutes les maladies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
8666 résultats correspondants
· 41 visibles sur cette page
dans le périmètre Toutes les maladies
Niveau clinique
Études et traitements 4050
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Rimiducid Étude non communiquée | Lupus | Immunomodulation | Phase 1 | Arrêté / suspendu | The purpose of this study is to evaluate the safety and tolerability of P-… À vérifier | ClinicalTrials.gov 2026-08-03 | Détail |
| Sham Exopulse Mollii Suit Étude non communiquée | Myopathies | Traitement symptomatique | Non applicable | Terminé | Cerebral Palsy (CP) is is estimated to be around 1.5-3 per live birth, wit… À vérifier | ClinicalTrials.gov 2026-08-03 | Détail |
| Sham group Étude non communiquée | Maladie de Parkinson | Thérapie génique | Non applicable | Prévu | Ischemic conditioning (IC) is a promising therapy that can mimic the physi… À vérifier | ClinicalTrials.gov 2026-08-03 | Détail |
| Sham radial extracorporeal shock wave therapy (rESWT) Étude non communiquée | Myopathies | Traitement symptomatique | Non applicable | Terminé | Spasticity is a major contributor to functional limitations in children wi… À vérifier | ClinicalTrials.gov 2026-08-03 | Détail |
| Sham Repetitive Transcranial Magnetic Stimulation (Sham rTMS) Étude non communiquée | Maladie de Parkinson | Traitement symptomatique | Non applicable | Actif | The purpose of this study is to evaluate the efficacy of repetitive transc… À vérifier | ClinicalTrials.gov 2026-08-03 | Détail |
| Sham treatment Étude non communiquée | Myopathies | Ralentissement de la progression · Traitement symptomatique | Non applicable | Actif | The aim of the study was to investigate the effectiveness of Manual Therap… À vérifier | ClinicalTrials.gov 2026-08-03 | Détail |
| 0.5mg elsunersen Étude non communiquée | Épilepsie | À vérifier | Phase 3 | Actif | A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| 1.5mg/kg/day PRAX-562 Étude non communiquée | Épilepsie | À vérifier | Phase 3 | Actif | A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Clin… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| 20 mg/day vormatrogine for 12 weeks Étude non communiquée | Épilepsie | À vérifier | Phase 3 | Actif | A multicenter, double-blind, randomized, placebo-controlled clinical trial… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| 30 mg/day vormatrogine for 12 weeks Étude non communiquée | Épilepsie | À vérifier | Phase 3 | Actif | A multicenter, double-blind, randomized, placebo-controlled clinical trial… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| AV-1980R 60 µg Étude non communiquée | Maladie d’Alzheimer | À vérifier | Phase 1 | Actif | This is a Phase 1, multicenter, randomized, double-blind, placebo-controll… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| AV-1980R 180 µg Étude non communiquée | Maladie d’Alzheimer | À vérifier | Phase 1 | Actif | This is a Phase 1, multicenter, randomized, double-blind, placebo-controll… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| axicabtagene ciloleucel Étude non communiquée | Sclérose en plaques | Immunomodulation · Thérapie cellulaire | Phase 3 | Actif | This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| belimumab, obinutuzumab or anifrolumab Étude non communiquée | Lupus | À vérifier | Phase 4 | Actif | The goal of this clinical study is to assess the efficacy and safety of LU… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| lisocabtagene maraleucel Étude non communiquée | Sclérose en plaques | Immunomodulation · Thérapie cellulaire | Phase 3 | Actif | This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| Multiple Tip Thermoablation Étude non communiquée | Cancer | Thérapie génique | Non applicable | Terminé | The purpose of this academic-industrial partnership will be to compare two… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| mycophenolic acid analog (MPAA) Étude non communiquée | Lupus | À vérifier | Phase 4 | Actif | The goal of this clinical study is to assess the efficacy and safety of LU… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| Operation Étude non communiquée | Hypertension artérielle | À vérifier | Non applicable | Prévu | Clinical outcome to identify and analyze the epigenetic, phenotypic, prote… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| PRAX-222 - Fixed Doses Étude non communiquée | Épilepsie | Thérapie génique | Phase 1/2 | Actif | The goal of this trial is to learn about the effect of PRAX-222 in pediatr… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
| PRAX-222 - Initial Ascending Doses Étude non communiquée | Épilepsie | Thérapie génique | Phase 1/2 | Actif | The goal of this trial is to learn about the effect of PRAX-222 in pediatr… À vérifier | ClinicalTrials.gov 2026-07-31 | Détail |
Découverte scientifique
Recherches et trouvailles 21
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Sclérose latérale amyotrophique | Neuroprotection · Immunomodulation | Découverte fondamentale | Exploratoire | Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… | Revue scientifique 2024-07-01 | Détail |
Bibliographie
Publications 4595
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Effects of testosterone-augmented multimodal exercise intervention in… Whole-body Electrical Muscle Stimulation Exercise · PMID 41988780 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Spinal cord injury (SCI) leads to profound muscle atrophy, aerobic deconditioning, and metabolic dysfunction. Exercise-… | The Journal of clinical endocrinology and metabolism 2026-09-20 04:37:05 | Source |
| Feasibility and acceptability of whole-body electromyostimulation in… Whole-body Electrical Muscle Stimulation Exercise · PMID 42464389 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Evidence on the effectiveness of electromyostimulation (EMS) has been reported in pulmonary rehabilitation, but the ben… | Pilot and feasibility studies 2026-09-20 04:37:05 | Source |
| Vestibular contributions adapt to the balance strategies adopted duri… Whole-body Electrical Muscle Stimulation Exercise · PMID 42616645 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Vestibular contributions during walking are not uniform, but vary with gait phase, muscle group, and balance demands. M… | Journal of neurophysiology 2026-09-20 04:37:05 | Source |
| Clinical efficacy of abdominal moxibustion at the Zhongji (CV3) in co… Yangyin Roujin Decoction · PMID 42015783 | Myopathies | Neuroprotection · Traitement symptomatique | Publication | PubMed | Voir la publication source To investigate the clinical effect of abdominal moxibustion at the Zhongji (CV3) combined with Yiqi Tonglin Yangyin dec… | Journal of traditional Chinese medicine = Chung i tsa… 2026-09-20 04:37:03 | Source |
| Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Tar… Yangyin Roujin Decoction · PMID 42713045 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source This study aimed to investigate the protective effects and underlying mechanisms of Yiqi Huoxue Yangyin Decoction (YHY)… | Diabetes, metabolic syndrome and obesity : targets and… 2026-09-20 04:37:03 | Source |
| Yiqi Huoxue Yangyin Decoction attenuates diabetic nephropathy in mice… Yangyin Roujin Decoction · PMID 42016924 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source Diabetic nephropathy (DN) is a major complication of diabetes with limited therapeutic options. Yiqi Huoxue Yangyin Dec… | Frontiers in pharmacology 2026-09-20 04:37:03 | Source |
| Barcoded oligonucleotide system (BOLT) for targeted organ delivery. Immunotherapy · PMID 42733790 | Cancer | À vérifier | Publication | PubMed | Voir la publication source The therapeutic potential of oligonucleotides (oligos) is limited by insufficient delivery to extrahepatic tissues. In… | Bioactive materials 2026-09-20 04:36:56 | Source |
| Dual metabolic checkpoint blockade a 3D-Printed metalloplatform remod… Immunotherapy · PMID 42724565 | Cancer | Immunomodulation | Publication | PubMed | Voir la publication source The immunosuppressive tumor microenvironment limits the efficacy of therapies that target metabolism. Here we show a st… | Bioactive materials 2026-09-20 04:36:56 | Source |
| Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-… Immunotherapy · PMID 42751513 | Cancer | Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Antigen cross-presentation by dendritic cells (DCs) is essential for inducing cytotoxic immune responses, which are cru… | Bioactive materials 2026-09-20 04:36:56 | Source |
| Feasibility and safety of early discharge after robot-assisted uro-on… Digital care pathway for hypertension · PMID 42671715 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source Early discharge after robot-assisted uro-oncologic surgery remains limited by concerns regarding patient safety and the… | Journal of robotic surgery 2026-09-20 04:36:49 | Source |
| HomeSafe: Postpartum Hypertensive Care Enabled by Electronic Health R… Digital care pathway for hypertension · PMID 41707683 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source The objective is to present stepwise refinements to , an Epic-tethered, population-health-coordinated postpartum pathwa… | American journal of perinatology 2026-09-20 04:36:49 | Source |
| Nutraceutical and functional food: efficacy against metabolic disorde… Digital care pathway for hypertension · PMID 42603698 | Hypertension artérielle | Neuroprotection · Immunomodulation | Publication | PubMed | Voir la publication source The growing global emphasis on health consciousness has significantly increased demand for traditional and complementar… | Journal of advanced research 2026-09-20 04:36:49 | Source |
| Community-engaged design of a virtual diabetes prevention program int… Asynchronous communication with nurse · PMID 42288862 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source The Diabetes Prevention Program (DPP) is an evidence-based approach to prevent Type 2 Diabetes (T2D), the leading cause… | BMC health services research 2026-09-20 04:36:48 | Source |
| Evolving Lung Cancer Navigator Practice Through Targeted Professional… Asynchronous communication with nurse · PMID 42463006 | Cancer | À vérifier | Publication | PubMed | Voir la publication source Lung cancer remains the leading cause of cancer deaths worldwide, and it has persistent disparities in detection, treat… | Chest 2026-09-20 04:36:48 | Source |
| Mass casualty training for prehospital and emergency providers in Kig… Asynchronous communication with nurse · PMID 42751142 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source A mass casualty incident (MCI) occurs when the number of patients exceeds available healthcare resources, placing signi… | African journal of emergency medicine : Revue africain… 2026-09-20 04:36:48 | Source |
| Innovating a Teach-Back Model for Community Health Workers Led Health… Health Literacy Project · PMID 40194526 | Épilepsie | À vérifier | Publication | PubMed | Voir la publication source From 2021 to 2023, the City of Albuquerque, the University of New Mexico (UNM) Office for Community Health, the UNM Hos… | Health literacy research and practice 2026-09-20 04:36:34 | Source |
| Carotid intima-media thickness may be an early biomarker for cardiova… Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 41026111 | Épilepsie | À vérifier | Publication | PubMed | Voir la publication source To assess early signs of atherosclerosis following long-term treatment with the ketogenic diet therapy due to concerns… | Epilepsia open 2026-09-20 04:36:33 | Source |
| Impact of low-carbohydrate diet on health status: an umbrella review. Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 39385794 | Cancer | À vérifier | Publication | PubMed | Voir la publication source The prevalence of diet-related non-communicable diseases has increased. A low-carbohydrate diet (LCDs) is one of the mo… | Frontiers in nutrition 2026-09-20 04:36:33 | Source |
| The effect of anti-seizure medications on lipid values in adults with… Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 37244221 | Épilepsie | À vérifier | Publication | PubMed | Voir la publication source Certain anti-seizure medications (ASMs) adversely impact lipid values. Here, we explored the impact of ASMs on lipid va… | Epilepsy & behavior : E&B 2026-09-20 04:36:33 | Source |
| Possible role of locus coeruleus neuronal loss in age-related memory… The Role of the Locus Coeruleus in Age-related Distractibility · PMID 37694113 | Maladie d’Alzheimer | Immunomodulation | Publication | PubMed | Voir la publication source Aging is associated with a decline in cognitive abilities, including memory and attention. It is generally accepted tha… | Frontiers in neuroscience 2026-09-20 04:36:30 | Source |
Exploration — prudence
Pistes exploratoires 0
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune piste exploratoire ne correspond aux filtres. | |||||||